QuadMedicine, Inc. (KOSDAQ:464490)

South Korea flag South Korea · Delayed Price · Currency is KRW
14,010
-320 (-2.23%)
At close: Apr 28, 2026
-41.50%
Market Cap 160.86B
Revenue (ttm) 10.70B
Net Income (ttm) -6.93B
Shares Out 11.48M
EPS (ttm) -722.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 90,465
Average Volume 101,081
Open 14,060
Previous Close 14,330
Day's Range 13,650 - 14,160
52-Week Range 12,460 - 27,150
Beta n/a
RSI 51.45
Earnings Date May 7, 2026

About QuadMedicine

QuadMedicine, Inc. engages in research, development, and production of healthcare vaccination needles based on the microneedle array patch (MAP). The company develops vaccinations for children living in remote areas to protect them from infectious diseases, such as diphtheria, tetanus, polio, measles, and hepatitis B. The company focuses on technology integration for medical and pharmaceutical microneedle development. It also provides fundamental MAP research through prototyping to MAP production for clinical trials. The company was incorporate... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2016
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 464490
Full Company Profile

Financial Performance

In 2025, QuadMedicine's revenue was 10.70 billion, an increase of 14.99% compared to the previous year's 9.30 billion. Losses were -6.93 billion, 39.5% more than in 2024.

Financial Statements

News

There is no news available yet.